Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?
Authors:
- Young Soo ParkYPYoung Soo Park
- Hee Sang HwangHHHee Sang Hwang
- Hye Jin ParkHPHye Jin Park
- Min-Hee RyuMRMin-Hee Ryu
- Heung-Moon ChangHCHeung-Moon Chang
- Jeong Hwan YookJYJeong Hwan Yook
- Byung Sik KimBKByung Sik Kim
- Se Jin JangSJSe Jin Jang
- Yoon-Koo KangYKYoon-Koo Kang
- 1 March 2012
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 43 (3) , 413-422
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Dual-color silver-enhanced in situ hybridization for assessing HER2 gene amplification in breast cancerLaboratory Investigation, 2011
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testingVirchows Archiv, 2010
- Cancer Statistics in Korea: Incidence, Mortality and Survival in 2006-2007Journal of Korean Medical Science, 2010
- Gastric cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-upAnnals of Oncology, 2009
- Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic ConsiderationsJournal of Clinical Oncology, 2009
- Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH)Diagnostic Pathology, 2008
- Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesisJournal of Cellular Physiology, 2007
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987